The Bio21 Institute has strategic relationships with a range of industry tenants from the R & D group of Australia's largest biopharmaceutical company - CSL Limited, to diverse start-up companies residing in the Institute's Incubator.
Our industry tenants include:
- CSL Limited R & D group who are focused on therapeutic discovery
- BioScreen Medical who focus on microbial diagnostics
- Sienna Cancer Diagnostics who focus on molecular biomarkers for specific tumours
- Prana Biotechnology Limited Chemistry R & D Laboratory who develop disease modifying therapeutics for the treatment of common neurological disorders, with a focus upon Alzheimer's, Parkinson's and Huntington's disease.
Back to top